1,826
Views
10
CrossRef citations to date
0
Altmetric
Original Investigation

Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis

, ORCID Icon, , , , , ORCID Icon, , & show all
Pages 214-227 | Received 22 Jan 2020, Accepted 24 May 2020, Published online: 09 Jul 2020

References

  • Abu-Akel A, Bousman C, Skafidas E, Pantelis C. 2018. Mind the prevalence rate: overestimating the clinical utility of psychiatric diagnostic classifiers. Psychol Med. 48(8):1225–1227.
  • American Psychiatric Association. 2009. Diagnostic and statistical manual of mental disorders. DSM-IV-TR. 4th ed. Arlington (VA): American Psychiatric Assoc.
  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. DSM-5 (5th ed). Washington (DC): American Psychiatric Publ. p. 947.
  • Arat HE, Chouinard V-A, Cohen BM, Lewandowski KE, Öngür D. 2015. Diffusion tensor imaging in first degree relatives of schizophrenia and bipolar disorder patients. Schizophr Res. 161(2–3):329–339.
  • Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. 2011. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage. 54(3):2033–2044.
  • Bartzokis G. 2011. Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments. Front Biosci (Landmark Ed)). 16:2695–2733.
  • Bennet L, Dhillon S, Lear CA, van den Heuij L, King V, Dean JM, Wassink G, Davidson JO, Gunn AJ. 2018. Chronic inflammation and impaired development of the preterm brain. J Reprod Immunol. 125:45–55.
  • Bergmann Ø, Henriques R, Westin C-F, Pasternak O. 2020. Fast and accurate initialization of the free-water imaging model parameters from multi-shell diffusion MRI. NMR Biomed. 33(3):e4219.
  • Bloemen OJN, de Koning MB, Schmitz N, Nieman DH, Becker HE, de Haan L, Dingemans P, Linszen DH, van Amelsvoort TAMJ. 2010. White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychol Med. 40(8):1297–1304.
  • Cannon TD. 2016. Brain biomarkers of vulnerability and progression to psychosis. Schizophr Bull. 42:S127–S132.
  • Chad JA, Pasternak O, Salat DH, Chen JJ. 2018. Re-examining age-related differences in white matter microstructure with free-water corrected diffusion tensor imaging. Neurobiol Aging. 71:161–170.
  • Cheung V, Chiu CPY, Law CW, Cheung C, Hui CLM, Chan KKS, Sham PC, Deng MY, Tai KS, Khong P-L, et al. 2011. Positive symptoms and white matter microstructure in never-medicated first episode schizophrenia. Psychol Med. 41(8):1709–1719.
  • Chung Y, Cannon TD. 2015. Brain imaging during the transition from psychosis prodrome to schizophrenia. J Nerv Ment Dis. 203(5):336–341.
  • Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, Kim PK, Ford CN, Higgs C, Hayes LN, et al. 2016. In vivo markers of inflammatory response in recent-onset schizophrenia. A combined study using (11)CDPA-713 PET and analysis of CSF and plasma. Transl Psychiatry. 6(4):e777–e777.
  • Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. 2003. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry. 60(5):443–456.
  • DeRosse P, Ikuta T, Peters BD, Karlsgodt KH, Szeszko PR, Malhotra AK. 2014. Adding insult to injury: childhood and adolescent risk factors for psychosis predict lower fractional anisotropy in the superior longitudinal fasciculus in healthy adults. Psychiatry Res. 224(3):296–302.
  • Di Biase MA, Katabi G, Piontkewitz Y, Cetin-Karayumak S, Weiner I, Pasternak O. 2020. Increased extracellular free-water in adult male rats following in utero exposure to maternal immune activation. Brain Behav Immun. 83:283–287.
  • Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M, et al. 2012. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 30(9):1323–1341.
  • Fu G, Zhang W, Dai J, Liu J, Li F, Wu D, Xiao Y, Shah C, Sweeney JA, Wu M, et al. 2019. Increased peripheral interleukin 10 relate to white matter integrity in schizophrenia. Front Neurosci. 13:52.
  • Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P. 2012. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 69(3):220–229.
  • Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, et al. 2013. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 70(1):107–120.
  • Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, Nieman DH, Stahl DR, Rutigliano G, Riecher-Rössler A, et al. 2016. Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry. 73(2):113–120.
  • Fusar-Poli P, Cappucciati M, Rutigliano G, Schultze-Lutter F, Bonoldi I, Borgwardt S, Riecher-Rössler A, Addington J, Perkins D, Woods SW, et al. 2015. At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry. 14(3):322–332.
  • Glenn GR, Kuo L-W, Chao Y-P, Lee C-Y, Helpern JA, Jensen JH. 2016. Mapping the orientation of white matter fiber bundles: a comparative study of diffusion tensor imaging, diffusional kurtosis imaging, and diffusion spectrum imaging. AJNR Am J Neuroradiol. 37(7):1216–1222.
  • Goldsmith DR, Rapaport MH, Miller BJ. 2016. A meta-analysis of blood cytokine network alterations in psychiatric patients. Comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 21(12):1696–1709.
  • Hartmann JA, Yuen HP, McGorry PD, Yung AR, Lin A, Wood SJ, Lavoie S, Nelson B. 2016. Declining transition rates to psychotic disorder in "ultra-high risk" clients. Investigation of a dilution effect. Schizophr Res. 170(1):130–136.
  • Jenkinson M, Bannister P, Brady M, Smith S. 2002. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 17(2):825–841.
  • Jeurissen B, Descoteaux M, Mori S, Leemans A. 2019. Diffusion MRI fiber tractography of the brain. NMR Biomed. 32(4):e3785
  • Karlsgodt KH, Niendam TA, Bearden CE, Cannon TD. 2009. White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry. 66(6):562–569.
  • Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13(2):261–276.
  • Keihaninejad S, Ryan NS, Malone IB, Modat M, Cash D, Ridgway GR, Zhang H, Fox NC, Ourselin S. 2012. The importance of group-wise registration in tract based spatial statistics study of neurodegeneration: a simulation study in Alzheimer's disease. PLoS One. 7(11):e45996
  • Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, et al. 2018. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry. 23(5):1261–1269.
  • Khoury R, Nasrallah HA. 2018. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait? Schizophr Res. 199:31–38.
  • Kochunov P, Hong LE. 2014. Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. Schizophr Bull. 40(4):721–728.
  • Krakauer K, Ebdrup BH, Glenthøj BY, Raghava JM, Nordholm D, Randers L, Rostrup E, Nordentoft M. 2017. Patterns of white matter microstructure in individuals at ultra-high-risk for psychosis: associations to level of functioning and clinical symptoms. Psychol Med. 47(15):2689–2707.
  • Kubicki M, Shenton ME. 2014. Diffusion Tensor Imaging findings and their implications in schizophrenia. Curr Opin Psychiatry. 27(3):179–184.
  • Kyriakopoulos M, Perez-Iglesias R, Woolley JB, Kanaan RAA, Vyas NS, Barker GJ, Frangou S, McGuire PK. 2009. Effect of age at onset of schizophrenia on white matter abnormalities. Br J Psychiatry. 195(4):346–353.
  • Leicht G, Vauth S, Polomac N, Andreou C, Rauh J, Mussmann M, et al. 2016. EEG-informed fMRI reveals a disturbed gamma-band-specific network in subjects at high risk for psychosis. Schizophrenia Bulletin. 42(1):239–249.
  • Ling J, Merideth F, Caprihan A, Pena A, Teshiba T, Mayer AR. 2012. Head injury or head motion? Assessment and quantification of motion artifacts in diffusion tensor imaging studies. Hum Brain Mapp. 33(1):50–62.
  • Lyall AE, Pasternak O, Robinson DG, Newell D, Trampush JW, Gallego JA, Fava M, Malhotra AK, Karlsgodt KH, Kubicki M, et al. 2018. Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning. Mol Psychiatry. 23(3):701–707.
  • Meyer U, Feldon J. 2012. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology. 62(3):1308–1321.
  • Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. 2011. Meta-analysis of cytokine alterations in schizophrenia. Clinical status and antipsychotic effects. Biol Psychiatry. 70(7):663–671.
  • Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW, et al. 2003. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 29(4):703–715.
  • Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, Yamauchi Y, Yamada S, Kanba S. 2013. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry. 42:115–121.
  • Mori S, Wakana S, van Zijl PCM, Nagae-Poetscher LM. 2005. MRI Atlas of human white matter. 1st ed. Amsterdam (The Netherlands): Elsevier Science. p. 276.
  • Moser DA, Doucet GE, Lee WH, Rasgon A, Krinsky H, Leibu E, Ing A, Schumann G, Rasgon N, Frangou S, et al. 2018. Multivariate associations among behavioral, clinical, and multimodal imaging phenotypes in patients with psychosis. JAMA Psychiatry. 75(4):386–395.
  • Mulert C, Kirsch V, Whitford TJ, Alvarado J, Pelavin P, McCarley RW, Kubicki M, Salisbury DF, Shenton ME. 2012. Hearing voices: a role of interhemispheric auditory connectivity? World J Biol Psychiatry. 13(2):153–158.
  • Najjar S, Pearlman DM. 2015. Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res. 161(1):102–112.
  • Pasternak O, Kelly S, Sydnor VJ, Shenton ME. 2018. Advances in microstructural diffusion neuroimaging for psychiatric disorders. Neuroimage. 182:259–282.
  • Pasternak O, Kubicki M, Shenton ME. 2016. In vivo imaging of neuroinflammation in schizophrenia. Schizophr Res. 173(3):200–212.
  • Pasternak O, Shenton ME, Westin C-F. 2012. Estimation of extracellular volume from regularized multi-shell diffusion MRI. Med Image Comput Comput Assist Interv. 15(Pt 2):305–312.
  • Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. 2009. Free water elimination and mapping from diffusion MRI. Magn Reson Med. 62(3):717–730.
  • Pasternak O, Westin C-F, Bouix S, Seidman LJ, Goldstein JM, Woo T-UW, Petryshen TL, Mesholam-Gately RI, McCarley RW, Kikinis R, et al. 2012. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci. 32(48):17365–17372.
  • Pasternak O, Westin C-F, Dahlben B, Bouix S, Kubicki M. 2015. The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia. Schizophr Res. 161(1):113–118.
  • Pettersson-Yeo W, Benetti S, Marquand AF, Dell‘Acqua F, Williams SCR, Allen P, Prata D, McGuire P, Mechelli A. 2013. Using genetic, cognitive and multi-modal neuroimaging data to identify ultra-high-risk and first-episode psychosis at the individual level. Psychol Med. 43(12):2547–2562.
  • Prasad KM, Upton CH, Nimgaonkar VL, Keshavan MS. 2015. Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study. Schizophr Res. 161(1):119–125.
  • Rigucci S, Santi G, Corigliano V, Imola A, Rossi-Espagnet C, Mancinelli I, De Pisa E, Manfredi G, Bozzao A, Carducci F, et al. 2016. White matter microstructure in ultra-high risk and first episode schizophrenia: A prospective study. Psychiatry Res Neuroimaging. 247:42–48.
  • Schmidt SJ, Schultze-Lutter F, Schimmelmann BG, Maric NP, Salokangas RKR, Riecher-Rössler A, van der Gaag M, Meneghelli A, Nordentoft M, Marshall M, et al. 2015. EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry. 30(3):388–404.
  • Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkotter J. 2007. Schizophrenia proneness instrument. Adult version (SPI-A). Rome: Giovanni Fioriti Editore. VII, p. 91 S.
  • Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BG, Maric NP, Salokangas RKR, Riecher-Rössler A, van der Gaag M, Nordentoft M, Raballo A, et al. 2015. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry. 30(3):405–416.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59 (Suppl 20):22–33.
  • Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rössler A, Borgwardt SJ, et al. 2010. Neuroimaging predictors of transition to psychosis-a systematic review and meta-analysis. Neurosci Biobehav Rev. 34(8):1207–1222.
  • Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, et al. 2006. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 31(4):1487–1505.
  • Smith SM, Nichols TE. 2009. Threshold-free cluster enhancement. Addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage. 44(1):83–98.
  • Szeszko PR, Robinson DG, Ikuta T, Peters BD, Gallego JA, Kane J, Malhotra AK. 2014. White matter changes associated with antipsychotic treatment in first-episode psychosis. Neuropsychopharmacol. 39(6):1324–1331.
  • Takahashi N, Sakurai T, Davis KL, Buxbaum JD. 2011. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol. 93(1):13–24.
  • Takahashi T, Suzuki M. 2018. Brain morphologic changes in early stages of psychosis: implications for clinical application and early intervention. Psychiatry Clin Neurosci. 72(8):556–571.
  • Tang Y, Pasternak O, Kubicki M, Rathi Y, Zhang T, Wang J, Li H, Woodberry KA, Xu L, Qian Z, et al. 2019. Altered cellular white matter but not extracellular free water on diffusion mri in individuals at clinical high risk for psychosis. Am J Psychiatry. 176(10):820–828.
  • Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S, et al. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (London, England). 362(9386):798–805.
  • Tognin S, van Hell HH, Merritt K, Winter-van Rossum I, Bossong MG, Kempton MJ, et al. 2020. Towards precision medicine in psychosis: benefits and challenges of multimodal multicenter studies-PSYSCAN: translating neuroimaging findings from research into clinical practice. Schizophr Bull. 46(2):432–441.
  • Tuch DS, Reese TG, Wiegell MR, van Wedeen J. 2003. Diffusion MRI of complex neural architecture. Neuron. 40(5):885–895.
  • Vijayakumar N, Bartholomeusz C, Whitford T, Hermens DF, Nelson B, Rice S, Whittle S, Pantelis C, McGorry P, Schäfer MR, et al. 2016. White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids. BMC Psychiatry. 16(1):287.
  • Vikhreva OV, Rakhmanova VI, Orlovskaya DD, Uranova NA. 2016. Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: a post-mortem morphometric study. Schizophr Res. 177(1-3):28–36.
  • Wang AK, Miller BJ. 2018. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients. Comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull. 44(1):75–83.
  • Wang C, Ji F, Hong Z, Poh JS, Krishnan R, Lee J, Rekhi G, Keefe RSE, Adcock RA, Wood SJ, et al. 2016. Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study. Psychol Med. 46(13):2771–2783.
  • Wassenaar TM, Yaffe K, van der Werf YD, Sexton CE. 2019. Associations between modifiable risk factors and white matter of the aging brain: insights from diffusion tensor imaging studies. Neurobiol Aging. 80:56–70.
  • Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. 2014. Permutation inference for the general linear model. Neuroimage. 92:381–397.
  • Wölwer W, Baumann A, Bechdolf A, Buchkremer G, Häfner H, Janssen B, Klosterkötter J, Maier W, Möller H-J, Ruhrmann S, et al. 2006. The German Research Network on schizophrenia–impact on the management of schizophrenia. Dialogues Clin Neurosci. 8(1):115–121.
  • Wood SJ, Yung AR, McGorry PD, Pantelis C. 2011. Neuroimaging and treatment evidence for clinical staging in psychotic disorders: from the at-risk mental state to chronic schizophrenia. Biol Psychiatry. 70(7):619–625. Available from: http://www.sciencedirect.com/science/article/pii/S0006322311005968.
  • Yang X, Cao D, Liang X, Zhao J. 2017. Schizophrenia symptomatic associations with diffusion tensor imaging measured fractional anisotropy of brain: a meta-analysis. Neuroradiology. 59(7):699–708.
  • Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, et al. 2005. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 39(11–12):964–971.